Correction to: Hepatocellular carcinoma (Nature Reviews Disease Primers, (2021), 7, 1, (6), 10.1038/s41572-020-00240-3)

Josep M. Llovet*, Robin Kate Kelley, Augusto Villanueva, Amit G. Singal, Eli Pikarsky, Sasan Roayaie, Riccardo Lencioni, Kazuhiko Koike, Jessica Zucman-Rossi, Richard S. Finn

*Corresponding author for this work

Research output: Contribution to journalComment/debate

Abstract

Correction to: Nature Reviews Disease Primershttps://doi.org/10.1038/s41572-020-00240-3, published online 21 January 2021. In the version of this article initially published, there was an error in Table 2: the second-to-last entry under Other outcomes, now reading “44 vs 30 months (Represents 5-year median recurrence-free survival),” appeared as “65% vs 70% (Represents 5-year progression-free survival)”. The table has been corrected in the HTML and PDF versions of the article.

Original languageAmerican English
Article number10
JournalNature Reviews Disease Primers
Volume10
Issue number1
DOIs
StatePublished - 12 Feb 2024

Bibliographical note

Publisher Copyright:
© Springer Nature Limited 2024.

Fingerprint

Dive into the research topics of 'Correction to: Hepatocellular carcinoma (Nature Reviews Disease Primers, (2021), 7, 1, (6), 10.1038/s41572-020-00240-3)'. Together they form a unique fingerprint.

Cite this